Principal Financial Group
KYMR icon

Principal Financial Group’s Kymera Therapeutics KYMR Stock Holding History

Principal Financial Group’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$345K Buy
4,147
+814
+24% +$64.5K ﹤0.01% 2056
2025
Q4 		$259K Sell
3,333
-525
-14% -$35.5K ﹤0.01% 2105
2025
Q3 		$218K Buy
+3,858
New +$174K ﹤0.01% 2160
2024
Q3 		– Sell
-8,190
Closed -$244K – 2323
2024
Q2 		$244K Sell
8,190
-3,908
-32% -$135K ﹤0.01% 2100
2024
Q1 		$486K Buy
12,098
+547
+5% +$19.6K ﹤0.01% 1989
2023
Q4 		$294K Sell
11,551
-32
-0.3% -$572 ﹤0.01% 2071
2023
Q3 		$161K Sell
11,583
-145
-1% -$2.92K ﹤0.01% 2199
2023
Q2 		$270K Sell
11,728
-651
-5% -$18.7K ﹤0.01% 2100
2023
Q1 		$367K Buy
12,379
+1,533
+14% +$49.4K ﹤0.01% 2043
2022
Q4 		$271K Buy
10,846
+967
+10% +$25.8K ﹤0.01% 2129
2022
Q3 		$215K Buy
+9,879
New +$260K ﹤0.01% 2188
2022
Q2 		– Sell
-12,048
Closed -$510K – 2586
2022
Q1 		$510K Buy
12,048
+71
+0.6% +$3K ﹤0.01% 2113
2021
Q4 		$760K Buy
11,977
+4,767
+66% +$278K ﹤0.01% 2038
2021
Q3 		$424K Buy
7,210
+2,589
+56% +$150K ﹤0.01% 2214
2021
Q2 		$224K Buy
+4,621
New +$201K ﹤0.01% 2442

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Principal Financial Group's KYMR Position: Q1 2026 in Review

Principal Financial Group increased its Kymera Therapeutics (KYMR) stake by 24% in Q1 2026, buying an estimated $64.5K and bringing the position to 4,147 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #2056.

Principal Financial Group first reported a position in KYMR in Q2 2021 and has held it in 15 quarters since. The position peaked at $760K in Q4 2021. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Principal Financial Group held 4,147 shares of Kymera Therapeutics worth $345K as of Q1 2026.
  • Principal Financial Group bought 814 Kymera Therapeutics shares in Q1 2026, an estimated $64.5K.
  • Kymera Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q1 2026, its #2056 holding.
  • Principal Financial Group first reported a position in Kymera Therapeutics in Q2 2021 and has held it in 15 quarters since.
  • Principal Financial Group's Kymera Therapeutics position peaked at $760K in Q4 2021.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.